Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting ...

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting Annexon Biosciences Mon, May 19 ...

Further analysis of efficacy data will be conducted in 2024. 15-HMedIdeS-09 is an open-label, single arm, trial evaluating the safety, tolerability and efficacy of imlifidase in GBS patients in ...

Kochi: Kochi: The first GBS death was on Tuesday reported in Kerala after a 58-year-old died of Guillain-Barre Syndrome in Kochi.The patient was undergoing treatment in Kottayam Medical College.

Another patient, a 16-year-old girl from Palghar, is in Nair Hospital with suspected GBS. So far, there are a total of 203 suspected cases and 176 confirmed cases in the state, with eight deaths.

While Pune has witnessed a sudden increase in Guillain-Barré Syndrome (GBS) cases since January 9, 2025 with most cases reported from the newly-merged villages, fresh suspected GBS cases have now ...